NEXT PHARMA LOGISTICS GMBH — Sitagliptin Importer Profile
Pharmaceutical Importer · #2 buyer for Sitagliptin · $2.7M import value · 86 shipments · GERMANY · DGFT Verified
NEXT PHARMA LOGISTICS GMBH is the #2 importer of Sitagliptin from India with $2.7M in import value and 86 verified shipments. NEXT PHARMA LOGISTICS GMBH holds a 5.7% market share in Sitagliptin imports based in GERMANY. The company sources from 3 verified suppliers across 68 formulations shipped to 2 countries.
NEXT PHARMA LOGISTICS GMBH — Sitagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sitagliptin to NEXT PHARMA LOGISTICS GMBH?
Verified from 86 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $1.7M | 58 | 65.0% |
| DR REDDY S LABORATORIES LIMITED | $822.6K | 20 | 30.7% |
| DR REDDYS LABORATORIES LIMITED | $116.1K | 8 | 4.3% |
NEXT PHARMA LOGISTICS GMBH sources Sitagliptin from 3 verified Indian suppliers based on 86 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 65.0% of imports.
How Does NEXT PHARMA LOGISTICS GMBH Compare to Nearest Sitagliptin Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | NEXT PHARMA LOGISTICS GMBH ★ | GERMANY | $4.3M | 86 | $50.0K |
| 4 | SUDAIR PHARMA COMPANY | SAUDI ARABIA | $3.2M | 78 | $41.6K |
| 3 | SANDOZ CANADA INC. C/O UPS SCS | CANADA | $3.0M | 61 | $50.0K |
NEXT PHARMA LOGISTICS GMBH ranks #2 among 575 Sitagliptin importers from India. Average shipment value of $50.0K compared to the market average of $44.6K. The closest competitors by value are SUDAIR PHARMA COMPANY and SANDOZ CANADA INC. C/O UPS SCS.
Where Does NEXT PHARMA LOGISTICS GMBH Import Sitagliptin To?
Destination countries from 86 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $2.0M | 69 | 73.5% |
| NETHERLANDS | $710.8K | 17 | 26.5% |
NEXT PHARMA LOGISTICS GMBH imports Sitagliptin to 2 countries. The primary destination is GERMANY receiving 73.5% of shipments worth $2.0M.
What Sitagliptin Formulations Does NEXT PHARMA LOGISTICS GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| SITAGLIPTINMET. BETA 50/1000MG FTB (1333 | $100.0K | 2 |
| SITAGLIPTIN MET.BETA 50/1000MG FTB196 (6718X196S=1316728 NOS) | $100.0K | 2 |
| SITAGLIPTIN MET BETA 50 1000MG FTB 196 13467X196S 2639532 NOS | $100.0K | 2 |
| SITAGLIPTIN BETA 100 MG FTB 98 17080X98S 1673840 NOS | $100.0K | 2 |
| SITAGLIPTIN MET BETA 50 1000MG FTB196 13306X196S 2607976 NOS | $100.0K | 2 |
| 300037099 SITAGLIPTIN MET. BETA 50/1000M | $97.6K | 2 |
| SITAGLIPTIN MET BETA 50/850MG FTB 196 (4944X196S=969024NOS) | $91.0K | 2 |
| SITAGLIPTIN MET BETA 50 850MG FTB196 3923X196S 768908 NOS | $70.2K | 2 |
| SITAGLIPTINMET BETA 50 1000MG FTB 196 3353X196S 657188 NOS | $63.4K | 2 |
| 300037090 SITAGLIPTIN BETA 100 MG FTB 98 | $62.4K | 2 |
NEXT PHARMA LOGISTICS GMBH imports 68 distinct Sitagliptin formulations from India. The top formulation is SITAGLIPTINMET. BETA 50/1000MG FTB (1333 with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Sitagliptin into Germany
What NEXT PHARMA LOGISTICS GMBH and other importers must comply with to import Sitagliptin from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Sitagliptin
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sitagliptin from India and How Much Does NEXT PHARMA LOGISTICS GMBH Import?
India exported $25.7M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. NEXT PHARMA LOGISTICS GMBH imports $2.7M of this total, accounting for 5.7% of India's Sitagliptin exports with 86 shipments from GERMANY. This is verified from 86 customs shipment records covering 68 distinct formulations.
What Is the Average Order Value for NEXT PHARMA LOGISTICS GMBH's Sitagliptin Imports?
NEXT PHARMA LOGISTICS GMBH's average Sitagliptin order value is $31.2K per consignment, based on 86 shipments totaling $2.7M. NEXT PHARMA LOGISTICS GMBH is based in GERMANY and ranks #2 among all Sitagliptin importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Sitagliptin to NEXT PHARMA LOGISTICS GMBH?
NEXT PHARMA LOGISTICS GMBH sources Sitagliptin from 3 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($1.7M, 65.0%), DR REDDY S LABORATORIES LIMITED ($822.6K, 30.7%), DR REDDYS LABORATORIES LIMITED ($116.1K, 4.3%). This is based on 86 customs records.
How Does NEXT PHARMA LOGISTICS GMBH Compare to Other Sitagliptin Importers?
NEXT PHARMA LOGISTICS GMBH ranks #2 among 575 Sitagliptin importers from India with a 5.7% market share. The top 3 importers are NEXT PHARMA LOGISTICS GMBH ($4.3M), SUDAIR PHARMA COMPANY ($3.2M), SANDOZ CANADA INC. C/O UPS SCS ($3.0M). NEXT PHARMA LOGISTICS GMBH processed 86 shipments from GERMANY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NEXT PHARMA LOGISTICS GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NEXT PHARMA LOGISTICS GMBH's capped import value divided by total capped export value for Sitagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 86 individual customs records matching NEXT PHARMA LOGISTICS GMBH importing Sitagliptin, covering 68 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Import Data for NEXT PHARMA LOGISTICS GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for NEXT PHARMA LOGISTICS GMBH's Sitagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NEXT PHARMA LOGISTICS GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
NEXT PHARMA LOGISTICS GMBH × Sitagliptin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NEXT PHARMA LOGISTICS GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current order-level data, contact TransData Nexus.